Serum Apolipoprotein C-III and Cardiovascular Events in Type 1 Diabetes

被引：0
|
作者：
Basu, Arpita
Bebu, Ionut
Jenkins, Alicia
Stoner, Julie
Zhang, Ying
Klein, Richard L.
Lopes-Virella, Maria F.
Garvey, W. Timothy
Budoff, Matthew
Lyons, Timothy
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-188-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria
    Sigfrids, Fanny Jansson
    Stechemesser, Lars
    Dahlstrom, Emma H.
    Forsblom, Carol M.
    Harjutsalo, Valma
    Weitgasser, Raimund
    Taskinen, Marja-Riitta
    Groop, Per-Henrik
    JOURNAL OF INTERNAL MEDICINE, 2022, 291 (03) : 338 - 349
  • [2] Glycogenosis type III shows markedly reduced serum apolipoprotein C-III sialylation
    Ondruskova, Nina
    Honzik, Tomas
    Kolarova, Hana
    Poupetova, Helena
    Zeman, Jiri
    Hansikova, Hana
    GLYCOBIOLOGY, 2015, 25 (11) : 1302 - 1303
  • [3] Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk
    Aroner, Sarah A.
    Yang, Ming
    Li, Junlong
    Furtado, Jeremy D.
    Sacks, Frank M.
    Tjonneland, Anne
    Overvad, Kim
    Cai, Tianxi
    Jensen, Majken K.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2017, 186 (06) : 736 - 744
  • [4] PLASMA APOLIPOPROTEIN C-III LEVELS IN CHILDREN WITH TYPE-I DIABETES
    BLACKETT, P
    SARALE, DC
    FESMIRE, J
    HARMON, J
    WEECH, P
    ALAUPOVIC, P
    SOUTHERN MEDICAL JOURNAL, 1988, 81 (04) : 469 - 473
  • [5] Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: Associations with lipoprotein subclasses
    Klein, RL
    McHenry, MB
    Lok, KH
    Hunter, SJ
    Le, NA
    Jenkins, AJ
    Zheng, D
    Semler, AJ
    Brown, WV
    Lyons, TJ
    Garvey, WT
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (10): : 1296 - 1304
  • [6] Whole-genome and whole-exome sequencing study of serum apolipoprotein C-III concentrations in individuals with type 1 diabetes
    Valo, E.
    Antikainen, A.
    Haukka, J.
    Sigfrids, F. Jansson
    Syreeni, A.
    Groop, P. -H.
    Sandholm, N.
    DIABETOLOGIA, 2024, 67 : S465 - S466
  • [7] Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
    Ooi, Esther M. M.
    Barrett, P. Hugh R.
    Chan, Dick C.
    Watts, Gerald F.
    CLINICAL SCIENCE, 2008, 114 (9-10) : 611 - 624
  • [8] Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease
    Kohan, Alison B.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2015, 22 (02) : 119 - 125
  • [9] Identification and purification of apolipoprotein C-III from the serum of cows
    Yamamoto, M
    Katoh, N
    Adachi, Y
    Oikawa, S
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1998, 59 (06) : 667 - 672
  • [10] QUANTIFICATION OF APOLIPOPROTEIN C-III IN SERUM BY A NONCOMPETITIVE IMMUNOENZYMOMETRIC ASSAY
    PARSY, D
    CLAVEY, V
    FIEVET, C
    KORA, I
    DURIEZ, P
    FRUCHART, JC
    CLINICAL CHEMISTRY, 1985, 31 (10) : 1632 - 1635
12345